ah yep.
it’s called sales.
and that’s been happening…
now we just need to see if that process speeds up and the numbers build.
nice also to see optionality in the form
of a big pharma product being developed parallel to core apas sales strategy.
so yep, things are changing imo
turning a small cap into a giant is an extraordinarily hard, time consuming long shot of a thing….obv coming with great reward at great risk.
gltah
let’s hope it comes in
Ann: Notice of Annual General Meeting/Proxy Form, page-5
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
